Republished with approval from DiabetesMine.com.
Another interesting development apropos to recent rants on lowering medical costs, in part by breaking down some traditional delivery mechanisms in favor of a more quick-shop, commercial approach to healthcare: now the FDA plans "to expand the the middle ground between drugs that require a prescription and those that anyone can buy off the shelf." This new gray area for medications is termed "behind the counter" (BTC).
BTC has already...
